Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors
Title:
Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors
Author:
Dumoulin, D. de Goeje, P. Poncin, M. Bezemer, K. Groen, H.J.M. Smit, E.F. Dingemans, A.-M.C. Kunert, A. Hendriks, R. Aerts, J.G.